» Articles » PMID: 16571833

Role of Endosomal Cathepsins in Entry Mediated by the Ebola Virus Glycoprotein

Overview
Journal J Virol
Date 2006 Mar 31
PMID 16571833
Citations 279
Authors
Affiliations
Soon will be listed here.
Abstract

Using chemical inhibitors and small interfering RNA (siRNA), we have confirmed roles for cathepsin B (CatB) and cathepsin L (CatL) in Ebola virus glycoprotein (GP)-mediated infection. Treatment of Ebola virus GP pseudovirions with CatB and CatL converts GP1 from a 130-kDa to a 19-kDa species. Virus with 19-kDa GP1 displays significantly enhanced infection and is largely resistant to the effects of the CatB inhibitor and siRNA, but it still requires a low-pH-dependent endosomal/lysosomal function. These and other results support a model in which CatB and CatL prime GP by generating a 19-kDa intermediate that can be acted upon by an as yet unidentified endosomal/lysosomal enzyme to trigger fusion.

Citing Articles

Single-Virus Microscopy of Biochemical Events in Viral Entry.

Cervantes M, Mannsverk S, Hess T, Filipe D, Villamil Giraldo A, Kasson P JACS Au. 2025; 5(1):399-407.

PMID: 39886585 PMC: 11775682. DOI: 10.1021/jacsau.4c00992.


Identification of Filovirus Entry Inhibitors from Marine Fungus-Derived Indole Alkaloids.

Wang L, Seravalli J, Eaton B, Liu Y, Holbrook M, Lan W Mar Drugs. 2025; 23(1).

PMID: 39852525 PMC: 11766795. DOI: 10.3390/md23010023.


Decoding the blueprint of receptor binding by filoviruses through large-scale binding assays and machine learning.

Lasso G, Grodus M, Valencia E, DeJesus V, Liang E, Delwel I Cell Host Microbe. 2025; 33(2):294-313.e11.

PMID: 39818205 PMC: 11825280. DOI: 10.1016/j.chom.2024.12.016.


Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus Infection.

Bu F, Ye G, Morsheimer K, Mendoza A, Turner-Hubbard H, Herbst M PLoS Pathog. 2024; 20(12):e1012817.

PMID: 39715280 PMC: 11723632. DOI: 10.1371/journal.ppat.1012817.


Endosomal fusion of pH-dependent enveloped viruses requires ion channel TRPM7.

Doyle C, Busey G, Iobst W, Kiessling V, Renken C, Doppalapudi H Nat Commun. 2024; 15(1):8479.

PMID: 39353909 PMC: 11445543. DOI: 10.1038/s41467-024-52773-w.


References
1.
Arunachalam B, Phan U, Geuze H, Cresswell P . Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci U S A. 2000; 97(2):745-50. PMC: 15401. DOI: 10.1073/pnas.97.2.745. View

2.
Wallin M, Loving R, Ekstrom M, Li K, Garoff H . Kinetic analyses of the surface-transmembrane disulfide bond isomerization-controlled fusion activation pathway in Moloney murine leukemia virus. J Virol. 2005; 79(22):13856-64. PMC: 1280236. DOI: 10.1128/JVI.79.22.13856-13864.2005. View

3.
Weidow C, Black D, Bliska J, Bouton A . CAS/Crk signalling mediates uptake of Yersinia into human epithelial cells. Cell Microbiol. 2001; 2(6):549-60. DOI: 10.1046/j.1462-5822.2000.00079.x. View

4.
Neumann G, Feldmann H, Watanabe S, Lukashevich I, Kawaoka Y . Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol. 2001; 76(1):406-10. PMC: 135697. DOI: 10.1128/jvi.76.1.406-410.2002. View

5.
Jane-Valbuena J, Breun L, Schiff L, Nibert M . Sites and determinants of early cleavages in the proteolytic processing pathway of reovirus surface protein sigma3. J Virol. 2002; 76(10):5184-97. PMC: 136125. DOI: 10.1128/jvi.76.10.5184-5197.2002. View